Texas BioResearch Product Faire™
As the largest state in the continental U.S. and the second most populous state of all 50, it is no wonder that the Lone Star State is known for being BIG. Amongst the big things in Texas are three world-class research institutions: University of Texas Austin, Texas A&M University in College Station, and Texas Medical Center in Houston.Read More
Researchers and fundraisers alike are passionate about finding innovative, new and more effective treatments for breast cancer in women. Breast cancer forms in the tissue of the breast, and the most common form is ductal carcinoma, which begins in the lining of the milk ducts. In 2014, 232,670 women were diagnosed with breast cancer, while the death rate for 2014 was 40,000 women.
The National Institute of Health recently awarded the University of Texas Austin School of Nursing a $2.4 million grant to establish a new research center that will largely focus on treating individual, family, and community chronic health conditions. As one of two institutions in the U.S. to receive this award, UT Austin will be a national model to future research centers of this type.Read More
The Department of Defense has awarded the University of Texas Austin, along with 11 other U.S. institutions, a 5 year award of $17 million to develop successful treatments for these injuries.Read More
It’s not an uncommon dream for cancer researchers and patients afflicted with cancer to find a way to make cancer cells self-destruct: Remarkably, cancer researchers at the University of Texas, Austin may have found a way to do just that. By ferrying sodium and chloride ions into the cancer cells, the cells are triggered to go through apoptosis, or a programmed cell death.
Researchers at the University of Texas at Austin have developed a combination of therapies to reduce the growth rate of human cancer.
This month the University of Texas at Austin received $2.4 million from Howard Hughes Medical Institute to expand its Freshman Research Initiative Program. Each year the Freshman Research Initiative Program offers about 800 first-year students the opportunity to take part in advanced research projects early in their academic careers.
Given the widespread use and abuse of alcohol for recreation, a drug that could interrupt its effects would have enormous value in treating alcoholism. Since addiction is based on stimulating pleasure centers, scientists have been looking for a way to block that interaction between alcohol and the brain. The challenge has been to find a key protein that carries out this transmission and identify its binding site. Now, biologists in the Harris Lab at the University of Texas Austin have made a major research breakthrough validating the importance of certain ligand-gated ion channels in that process and locating a cavity where the binding takes place. Remarkably, they were able to push their research forward thanks to an obscure alpine cyanobacteria recently sequenced in France.
Everyone wants to live healthier, if only to avoid the distress and danger of having serious problems like diabetes and blocked arteries. Unfortunately that's not always enough to get Americans to eat better, even when they know what's at stake. Last month a much publicized study in the New England Journal of Medicine confirmed that a "Mediterranean diet" is a clear winner for heart health, but try wrestling a steak away from a Texan with the lure of olive oil, nuts, and fruit instead. That's why University of Texas Health Science Center San Antonio (UTHSCSA) research scientist Reto Asmis is studying the biochemical basis of the Mediterranean diet with the aim of producing a food supplement that does what the healthy diet does without a wholesale change in our eating behavior.
Tags: 2014, 2013, cardiovascular research, heart disease, food science, Mediterranean Diet, University of Texas, Translational Research, Texas, Southwest, UT Health Science Center San Antonio, UTxSA, University of Texas Health Science Center, BioResearch Product Faire Event, San Antonio, TX